Olema Oncology receives $180M in total funding

Tyler Patchen

News Reporter

Olema Oncology, the Bay Area biotech run by former AstraZeneca executive Sean Bohen, raised $130 million from a private placement and a credit facility of …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Olema Oncology receives $180M in total funding

Tyler Patchen

News Reporter

Sign up to read this article for free.

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

Bluebird bio to sell to investment funds after struggling to make money from gene therapies

FDA says Ozempic, Wegovy shortage is over

Kevin Tang's Concentra tries to disrupt proposed Acelyrin-Alumis merger

Pfizer ends rollout of Beqvez, putting another dent in hemophilia gene therapy field

Merck KGaA tees up changes to leadership team; Ex-CVS Health CEO joins Thermo Fisher’s board

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence

Ole­ma On­col­o­gy re­ceives $180M in to­tal fund­ing

News Reporter

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

Olema Oncology receives $180M in total funding